This paper analyses the integrated circuit and pharmaceutical GVCs to determine the scope of technical upgrading and value capture achieved by Chinese and Indian contract R&D firms within these GVCs. There are three main findings. First, the two sectors differ significantly in terms of the...

There is mounting evidence of a widespread popular backlash against globalization in advanced economies, which can hurt multinational companies' (MNCs) interests. In this paper we argue that MNCs are both ‘culprits' and ‘victims' of backlash against globalization. Building on the comparative...

India and China have taken very different developmental paths in integrated circuit design. India has engaged with multinationals and emphasized design service. China has focused more on homegrown fabless firms designing their own chips. These two different routes have led to very different...